The Role of IL-17 in fungal keratitis

IL-17在真菌性角膜炎中的作用

基本信息

  • 批准号:
    8398091
  • 负责人:
  • 金额:
    $ 5.22万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-08-01 至 2014-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): IL-17 and Th17 cells have an important role in the host response to fungal infections. In the current study, we examined the role of IL-17 in a murine model of Aspergillus and Fusarium infections of the cornea, which are a major cause of blindness and visual impairment worldwide. C57BL/6 mice immunized by intratracheal or subcutaneous routes. Mice immunized by either route demonstrated rapid fungal clearance and significantly reduced corneal disease compared with unimmunized, infected mice which severe corneal opacity and a persistent fungal presence. Intracellular flow cytometry showed development of fungal-specific Th1 and Th17 cells in the spleen following immunization, which were selectively recruited to the cornea after infection (Th17 cells at 48h, and Th1 cells at 72h). Neutralization of IL-17 following immunization, or infection of IL-17-/- mice inhibited the protective phenotype, whereas IFN-? neutralization had no effect. A discrete population of IL-17 producing neutrophils was detected in the corneas 24h after infection corneas of immunized, but not unimmunized mice, and were detected in the spleen and bone marrow. Further, neutrophil depletion impaired IL-17 production at this time and blocked protective immunity. IL-17 producing neutrophils produced elevated ROS and had increased capacity to kill hyphae in vitro, indicating that this population of cells has an important role in regulating fungal infectio. Quantitative PCR of the FACS sorted IL-17 neutrophils from the cornea, spleen and bone marrow showed IL-17 transcripts, indicating de novo synthesis. Further, naive bone marrow neutrophils expressed IL-17 RNA when incubated with splenocyte supernatants from immunized mice, and expression was ablated in the presence of both anti-IL-6 and anti-IL-23. Conversely, stimulation with both IL-16 and IL-23, but not with single Abs stimulated IL-17 expression. Together, these data indicate that IL-17 producing neutrophils are generated by IL-6 and IL-23 in immunized mice, and are recruited to fungal infected corneas, resulting in rapid fungal clearance possibly due to elevated production of reactive oxygen species or interactions with Th17 cells. These findings show a role for IL-17, Th17, and IL-17 producing neutrophils in regulating fungal infections. In the proposed experiments I will determine the relative contribution of Th17 cells and IL-17 producing cells in protective immunity in fungal keratitis. ) PUBLIC HEALTH RELEVANCE: Project narrative: Fungal keratitis is one of the leading causes of corneal ulcers, visual impairment, and blindness. In many cases the current anti-fungal treatments for this infection are not adequate in resolving the disease. However, the results from the proposed studies could lead to proper regulation and novel therapies for this debilitating infection.
描述(由申请人提供):IL-17 和 Th17 细胞在宿主对真菌感染的反应中发挥重要作用。在当前的研究中,我们研究了 IL-17 在角膜曲霉菌和镰刀菌感染的小鼠模型中的作用,这些感染是全世界失明和视力障碍的主要原因。 C57BL/6小鼠通过气管内或皮下途径免疫。与未免疫、感染的小鼠相比,通过任一途径免疫的小鼠均表现出快速的真菌清除能力,并显着减少了角膜疾病,而感染的小鼠出现严重的角膜混浊和持续的真菌存在。细胞内流式细胞术显示,免疫后脾脏中出现了真菌特异性 Th1 和 Th17 细胞,这些细胞在感染后选择性地募集至角膜(48 小时时的 Th17 细胞,72 小时时的 Th1 细胞)。 免疫后IL-17的中和或IL-17-/-小鼠的感染抑制了保护性表型,而IFN-α中和没有效果。 在感染免疫小鼠而非未免疫小鼠的角膜后24小时,在角膜中检测到产生IL-17的中性粒细胞的离散群体,并且在脾脏和骨髓中检测到。此外,中性粒细胞耗竭此时损害了 IL-17 的产生并阻断了保护性免疫。产生 IL-17 的中性粒细胞产生的 ROS 升高,并且体外杀死菌丝的能力增强,表明该细胞群在调节真菌感染中具有重要作用。来自角膜、脾脏和骨髓的 FACS 分选的 IL-17 中性粒细胞的定量 PCR 显示了 IL-17 转录物,表明从头合成。此外,当与免疫小鼠的脾细胞上清液一起孵育时,幼稚骨髓中性粒细胞表达IL-17 RNA,并且在抗IL-6和抗IL-23存在的情况下表达被消除。相反,用IL-16和IL-23刺激IL-17表达,但用单一抗体刺激则不刺激IL-17表达。总之,这些数据表明,产生 IL-17 的中性粒细胞是由免疫小鼠中的 IL-6 和 IL-23 产生的,并被募集到真菌感染的角膜,导致真菌快速清除,这可能是由于活性氧的产生增加或与 Th17 细胞的相互作用所致。这些发现表明 IL-17、Th17 和产生 IL-17 的中性粒细胞在调节真菌感染中发挥作用。在拟议的实验中,我将确定 Th17 细胞和 IL-17 产生细胞在真菌性角膜炎的保护性免疫中的相对贡献。 ) 公共卫生相关性: 项目叙述:真菌性角膜炎是角膜溃疡、视力障碍和失明的主要原因之一。在许多情况下,目前针对这种感染的抗真菌治疗不足以解决该疾病。然而,拟议研究的结果可能会导致对这种使人衰弱的感染进行适当的监管和新的疗法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Patricia R Taylor其他文献

Patricia R Taylor的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Patricia R Taylor', 18)}}的其他基金

The role of IL-17A in the onset and progression of diabetic retinopathy in VA patients
IL-17A 在 VA 患者糖尿病视网膜病变发生和进展中的作用
  • 批准号:
    10426051
  • 财政年份:
    2021
  • 资助金额:
    $ 5.22万
  • 项目类别:
The role of IL-17A in the onset and progression of diabetic retinopathy in VA patients
IL-17A 在 VA 患者糖尿病视网膜病变发生和进展中的作用
  • 批准号:
    10657466
  • 财政年份:
    2021
  • 资助金额:
    $ 5.22万
  • 项目类别:
Identification of Immunomodulators for Diabetic Retinopathy Therapeutics
糖尿病视网膜病变治疗的免疫调节剂的鉴定
  • 批准号:
    10132337
  • 财政年份:
    2020
  • 资助金额:
    $ 5.22万
  • 项目类别:
Identification of Immunomodulators for Diabetic Retinopathy Therapeutics
糖尿病视网膜病变治疗的免疫调节剂的鉴定
  • 批准号:
    10382423
  • 财政年份:
    2020
  • 资助金额:
    $ 5.22万
  • 项目类别:
Identification of Immunomodulators for Diabetic Retinopathy Therapeutics
糖尿病视网膜病变治疗的免疫调节剂的鉴定
  • 批准号:
    10617636
  • 财政年份:
    2020
  • 资助金额:
    $ 5.22万
  • 项目类别:
The role of IL-17 neutrophils and lymphocytes during diabetic retinopathy
IL-17 中性粒细胞和淋巴细胞在糖尿病视网膜病变中的作用
  • 批准号:
    9137364
  • 财政年份:
    2016
  • 资助金额:
    $ 5.22万
  • 项目类别:
The role of IL-17 neutrophils and lymphocytes during diabetic retinopathy
IL-17 中性粒细胞和淋巴细胞在糖尿病视网膜病变中的作用
  • 批准号:
    9898287
  • 财政年份:
    2016
  • 资助金额:
    $ 5.22万
  • 项目类别:
The Role of IL-17 in fungal keratitis
IL-17在真菌性角膜炎中的作用
  • 批准号:
    8521211
  • 财政年份:
    2012
  • 资助金额:
    $ 5.22万
  • 项目类别:

相似海外基金

Extending the utility and durability of antifungal agents via innovative treatment regimens that minimise drug resistance
通过创新治疗方案最大限度地减少耐药性,延长抗真菌药物的效用和持久性
  • 批准号:
    MR/Y002164/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.22万
  • 项目类别:
    Research Grant
Engineering microbial cell factories for production of improved polyene antifungal agents
工程微生物细胞工厂用于生产改进的多烯抗真菌剂
  • 批准号:
    2898887
  • 财政年份:
    2023
  • 资助金额:
    $ 5.22万
  • 项目类别:
    Studentship
Morphological profiling for the development of antifungal agents
用于开发抗真菌药物的形态分析
  • 批准号:
    22H02216
  • 财政年份:
    2022
  • 资助金额:
    $ 5.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
An efficient approach to find therapeutically effective antifungal agents
寻找治疗有效的抗真菌药物的有效方法
  • 批准号:
    22K05337
  • 财政年份:
    2022
  • 资助金额:
    $ 5.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigating light-activated therapeutic compounds as antifungal agents.
研究光激活治疗化合物作为抗真菌剂。
  • 批准号:
    2753345
  • 财政年份:
    2022
  • 资助金额:
    $ 5.22万
  • 项目类别:
    Studentship
Discovery of novel therapeutic agents for biliary tract and pancreatic cancer based on antifungal agents
基于抗真菌药物的胆道癌和胰腺癌新型治疗药物的发现
  • 批准号:
    20H03533
  • 财政年份:
    2020
  • 资助金额:
    $ 5.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of antifungal agents that target essential protein kinases in A. fumigatus.
开发针对烟曲霉必需蛋白激酶的抗真菌剂。
  • 批准号:
    2456629
  • 财政年份:
    2020
  • 资助金额:
    $ 5.22万
  • 项目类别:
    Studentship
Development of Broad Spectrum Antifungal Agents
广谱抗真菌药物的开发
  • 批准号:
    9909111
  • 财政年份:
    2020
  • 资助金额:
    $ 5.22万
  • 项目类别:
Elucidation of tip growth factor of fungi and construction of screeing system for antifungal agents
真菌尖端生长因子的阐明及抗真菌药物筛选体系的构建
  • 批准号:
    19K05738
  • 财政年份:
    2019
  • 资助金额:
    $ 5.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Ambruticins: An inspiration to develop novel biocatalysts and antifungal agents
Ambruticins:开发新型生物催化剂和抗真菌剂的灵感
  • 批准号:
    2107517
  • 财政年份:
    2018
  • 资助金额:
    $ 5.22万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了